This important initiative, the 1st International NASH Day, has started by The NASH Education Program, an independent endowment fund set-up to increase awareness about NonAlcoholic SteatoHepatitis (NASH), a growing silent liver disease.
Antaros Medical is joining the call to spread the information worldwide.
In addition, Lars Johansson, CSO Antaros Medical, were invited to give a talk around Imaging of NASH during the AstraZeneca gathering for the 1st International NASH Day. He discussed how imaging can support disease understanding and drug development, not the least by adding important holistic perspectives including both NASH pathophysiology and cardiovascular effects.
Learn more on: